Affinage

ATP6V1B1

V-type proton ATPase subunit B, kidney isoform · UniProt P15313

Length
513 aa
Mass
56.8 kDa
Annotated
2026-04-28
33 papers in source corpus 11 papers cited in narrative 9 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

ATP6V1B1 encodes the B1 catalytic subunit of the vacuolar H⁺-ATPase (V-ATPase), functioning as an essential driver of proton secretion in specialized epithelial cells of the kidney collecting duct and inner ear. In the kidney, B1 is required both for apical H⁺ secretion in acid-secreting type A intercalated cells and for basolateral V-ATPase assembly and pendrin-dependent HCO₃⁻ secretion in non-type A intercalated cells, as demonstrated by knockout mice that exhibit impaired urinary acidification under acid load and blunted defense against alkalosis (PMID:29843146, PMID:37990364). In the inner ear, loss of ATP6V1B1 disrupts endolymph pH homeostasis, causing enlarged endolymphatic compartments and sensorineural hearing loss, a phenotype modulated by strain-specific genetic modifiers (PMID:28934385). Autosomal recessive loss-of-function mutations in ATP6V1B1 cause distal renal tubular acidosis with sensorineural deafness in humans (PMID:12414817).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2000 High

    Identification of ATP6V1B1 as the disease gene for autosomal recessive distal renal tubular acidosis with sensorineural deafness established the B1 subunit as a non-redundant component of renal acid secretion and inner ear ion homeostasis.

    Evidence Linkage analysis and mutational screening in multiple rdRTA kindreds

    PMID:12414817 PMID:12500243 PMID:12579397

    Open questions at the time
    • The molecular mechanism by which B1 loss impairs inner ear function was not resolved
    • Compensation by the B2 isoform was not assessed
    • No animal model existed to dissect renal vs. otic phenotypes
  2. 2003 High

    Cloning and tissue-level mapping of murine Atp6v1b1 confirmed restricted expression in kidney intercalated cells and testis, providing an animal system to study B1 function.

    Evidence Molecular cloning, Northern blotting, and immunolocalization in mouse kidney

    PMID:14585495

    Open questions at the time
    • Functional consequences of B1 loss in vivo were not yet tested
    • Expression in non-renal, non-testicular tissues was not systematically examined
  3. 2017 High

    A spontaneous Atp6v1b1 mutant mouse demonstrated that B1 is required for endolymph pH homeostasis and that the severity of hearing loss is governed by strain-specific genetic modifiers, explaining variable penetrance of deafness in human patients.

    Evidence ABR thresholds, inner ear morphology, and backcross linkage analysis in MRL-background vtx mutant mice versus B6 knockouts

    PMID:28934385

    Open questions at the time
    • The modifier gene(s) on chromosome 13 were not identified
    • Whether endolymphatic pH change directly damages hair cells or acts indirectly was not resolved
  4. 2018 High

    Atp6v1b1 knockout and heterozygous mice under acid load revealed that even partial B1 loss impairs urinary acidification, and that compensatory downregulation of pendrin occurs without redistribution of other V-ATPase subunits, indicating non-redundancy of B1 in acid-secreting intercalated cells.

    Evidence Atp6v1b1+/+, +/−, and −/− mice with HCl acid loading; renal membrane fractionation and immunolocalization

    PMID:29843146

    Open questions at the time
    • Whether B2 partially compensates at the functional level was not quantified
    • The mechanism linking B1 loss to pendrin downregulation in type A cells was unclear
  5. 2020 Medium

    CRISPR knockout of ATP6V1B1 in HER2⁺ breast cancer cells showed that B1-dependent V-ATPase activity maintains intracellular pH permissive for granzyme bioactivity, extending the functional relevance of B1 beyond kidney and ear to tumor immune evasion.

    Evidence CRISPR/Cas9 KO in SKBR3 and JIMT-1 cells; intracellular pH measurement; ADCC assays

    PMID:33000417

    Open questions at the time
    • Whether B1 is normally expressed at physiologically relevant levels in breast cancer tissue in vivo is unclear
    • Direct biochemical link between pH change and granzyme inactivation was not reconstituted
  6. 2021 Medium

    Minigene assays demonstrated that several exonic ATP6V1B1 variants cause disease not through missense effects but by disrupting exonic splicing enhancers, revealing an underappreciated mutational mechanism in rdRTA pathogenesis.

    Evidence Minigene splicing assays and RT-PCR for four exonic variants

    PMID:34157794

    Open questions at the time
    • Splicing effects were shown in heterologous minigene systems, not patient-derived cells
    • Impact on V-ATPase assembly and proton transport was not measured
  7. 2023 High

    Studies in non-type A intercalated cells resolved that B1 is essential not only for apical acid secretion but also for basolateral V-ATPase assembly and pendrin-mediated bicarbonate secretion during alkalosis, fundamentally expanding the role of B1 to alkali defense.

    Evidence Atp6v1b1−/− mice with alkali loading; ex vivo microperfused collecting ducts; proximity ligation assays for V0–V1 assembly

    PMID:37990364

    Open questions at the time
    • Whether B1 directly facilitates V0–V1 assembly or acts indirectly through scaffolding interactions was not determined
    • Relevance of this basolateral role to inner ear pathology is unknown
  8. 2025 Medium

    Knockdown of ATP6V1B1 in primary dendritic cells increased HIV-1 entry by altering endosomal pH and impairing endocytosis, demonstrating a role for B1-dependent acidification in innate antiviral restriction.

    Evidence shRNA knockdown in monocyte-derived dendritic cells; HIV-1 infection, endocytosis, and phagocytosis assays

    PMID:40029073

    Open questions at the time
    • Whether this reflects physiological B1 expression levels in dendritic cells in vivo is unknown
    • The specific endosomal compartment affected was not identified

Open questions

Synthesis pass · forward-looking unresolved questions
  • The structural basis of B1 versus B2 isoform-specific functions, the identity of genetic modifiers controlling hearing loss penetrance, and the mechanism by which B1 loss alters V0–V1 assembly remain unresolved.
  • No high-resolution structure of B1-containing V-ATPase holoenzyme exists
  • Chromosome 13 modifier gene(s) for hearing loss have not been identified
  • Direct protein–protein interactions mediating B1-dependent V0–V1 assembly are uncharacterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140657 ATP-dependent activity 3
Localization
GO:0005768 endosome 2 GO:0005886 plasma membrane 2
Pathway
R-HSA-382551 Transport of small molecules 3
Complex memberships
V-ATPase

Evidence

Reading pass · 9 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2000 Mutations in ATP6V1B1, encoding the B1 subunit of the renal alpha-intercalated cell apical H+-ATPase, cause autosomal recessive distal renal tubular acidosis (rdRTA) with sensorineural deafness, establishing ATP6V1B1 as a critical component of apical H+ secretion in collecting duct alpha-intercalated cells. Linkage analysis and mutational analysis in rdRTA kindreds; loss-of-function mutations identified in ATP6V1B1 Journal of medical genetics High 12414817 12500243 12579397
2003 Murine Atp6v1b1 encodes a 513-amino acid B1 subunit with 93% identity to human ATP6V1B1; it is expressed in kidney and testis, and localizes to intercalated cells of the cortical and medullary collecting duct by Northern blotting and immunolocalization. Molecular cloning, Northern blotting, immunolocalization in mouse kidney; chromosomal mapping Gene High 14585495
2018 In Atp6v1b1 knockout mice, loss of the B1 subunit impairs urinary acidification, and heterozygous Atp6v1b1+/- mice develop a mild incomplete distal RTA under acid load; compensatory downregulation of pendrin occurs specifically in collecting duct of knockout mice, and subcellular localization of a4 and B2 H+-ATPase subunits is unchanged across genotypes. Atp6v1b1+/+, +/-, and -/- mouse models; HCl acid-loading; renal membrane fractionation; immunolocalization of H+-ATPase subunits Cellular physiology and biochemistry High 29843146
2023 In non-type A (alkali-secreting) intercalated cells, the B1 H+-ATPase subunit is required for driving pendrin (Cl-/HCO3- exchanger) activity and for the renal defense against alkalosis; Atp6v1b1 knockout mice show impaired pendrin expression and activity, blunted β2-adrenergic stimulation of pendrin, strongly reduced basolateral H+-ATPase activity, and impaired assembly of V0 and V1 H+-ATPase domains as shown by ligation assays. Atp6v1b1-/- mouse model; ex vivo microperfused cortical collecting duct assays; alkali load and furosemide treatment protocols; ligation assays for H+-ATPase subunit assembly; immunostaining Journal of the American Society of Nephrology High 37990364
2017 Atp6v1b1 mutant mice on the MRL background exhibit profound hearing impairment associated with enlarged endolymphatic compartments of the inner ear and alkaline urine without overt metabolic acidosis, demonstrating that ATP6V1B1 is required for endolymph pH homeostasis in the inner ear; the hearing phenotype is modulated by strain-specific genetic modifiers mapping to chromosome 13. Spontaneous Atp6v1b1 mutant (vtx) mice on MRL background; ABR threshold measurements; backcross linkage analysis; comparison to B6 background knockout mice Human molecular genetics High 28934385
2020 ATP6V1B1 knockout in HER2+ breast cancer cells (SKBR3 and JIMT-1) using CRISPR/Cas9 significantly lowers intracellular pH, causes granzyme accumulation without cytotoxicity, and reduces susceptibility to antibody-dependent cellular cytotoxicity (ADCC), demonstrating that ATP6V1B1-dependent vacuolar ATPase activity maintains cytoplasmic pH permissive for granzyme bioactivity. CRISPR/Cas9 knockout; intracellular pH measurement; granzyme dynamics analysis; ADCC assays in HER2+ cancer cell lines Cancer immunology, immunotherapy Medium 33000417
2021 Several exonic variants in ATP6V1B1 (c.368G>T, p.Gly123Val; c.370C>T, p.Arg124Trp; c.484G>T, p.Glu162*; c.1102G>A, p.Glu368Lys) cause complete or incomplete exon skipping by disrupting exonic splicing enhancers or interfering with splice site recognition, as demonstrated by minigene splicing assay. Minigene splicing assay; bioinformatics splice prediction; RT-PCR Human mutation Medium 34157794
2024 ATP6V1B1 promotes ovarian cancer cell proliferation, migration, and invasion in vitro, and tumor growth in vivo; knockdown increases cisplatin sensitivity; mechanistic studies showed ATP6V1B1 regulates activation of the mTOR/autophagy pathway. Gain- and loss-of-function experiments; in vivo tumor xenograft; mTOR/autophagy pathway analysis Molecular and cellular biochemistry Low 38735913
2025 shRNA-mediated knockdown of ATP6V1B1 in primary monocyte-derived dendritic cells increases HIV-1 entry, associated with changes in endosomal pH and impaired fluid-phase endocytosis and phagocytosis, indicating that ATP6V1B1-dependent endosomal acidification restricts HIV-1 productive infection in dendritic cells. shRNA knockdown screen in primary MDDCs; HIV-1 infection assay with Vpx-VLPs; endocytosis and phagocytosis assays Journal of virology Medium 40029073

Source papers

Stage 0 corpus · 33 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2002 Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. Journal of medical genetics 223 12414817
1988 Isolation of genes encoding the Neurospora vacuolar ATPase. Analysis of vma-2 encoding the 57-kDa polypeptide and comparison to vma-1. The Journal of biological chemistry 150 2844751
1995 Diversity among the gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB. Antimicrobial agents and chemotherapy 78 8540711
2002 Confirmation of the ATP6B1 gene as responsible for distal renal tubular acidosis. Pediatric nephrology (Berlin, Germany) 40 12579397
2013 Molecular diagnosis of distal renal tubular acidosis in Tunisian patients: proposed algorithm for Northern Africa populations for the ATP6V1B1, ATP6V0A4 and SCL4A1 genes. BMC medical genetics 36 24252324
2012 Homozygous and compound heterozygous mutations in the ATP6V1B1 gene in patients with renal tubular acidosis and sensorineural hearing loss. Clinical genetics 33 22509993
2003 ATP6B1 gene mutations associated with distal renal tubular acidosis and deafness in a child. American journal of kidney diseases : the official journal of the National Kidney Foundation 26 12500243
2003 Molecular cloning and characterization of Atp6v1b1, the murine vacuolar H+ -ATPase B1-subunit. Gene 24 14585495
2016 Mutations in ATP6V1B1 and ATP6V0A4 genes cause recessive distal renal tubular acidosis in Mexican families. Molecular genetics & genomic medicine 23 27247958
2014 The contribution of Candida albicans vacuolar ATPase subunit V₁B, encoded by VMA2, to stress response, autophagy, and virulence is independent of environmental pH. Eukaryotic cell 23 25038082
2013 Mutational analyses of the ATP6V1B1 and ATP6V0A4 genes in patients with primary distal renal tubular acidosis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 21 23729491
2021 Identification of seven exonic variants in the SLC4A1, ATP6V1B1, and ATP6V0A4 genes that alter RNA splicing by minigene assay. Human mutation 20 34157794
2006 Molecular investigation and long-term clinical progress in Greek Cypriot families with recessive distal renal tubular acidosis and sensorineural deafness due to mutations in the ATP6V1B1 gene. Clinical genetics 19 16433694
2020 Downregulated ATP6V1B1 expression acidifies the intracellular environment of cancer cells leading to resistance to antibody-dependent cellular cytotoxicity. Cancer immunology, immunotherapy : CII 16 33000417
2017 Hearing loss without overt metabolic acidosis in ATP6V1B1 deficient MRL mice, a new genetic model for non-syndromic deafness with enlarged vestibular aqueducts. Human molecular genetics 16 28934385
2010 Novel ATP6V1B1 mutations in distal renal tubular acidosis and hearing loss. Acta oto-laryngologica 16 20233014
2013 ATP6V1B1 mutations in distal renal tubular acidosis and sensorineural hearing loss: clinical and genetic spectrum of five families. Renal failure 13 23923981
2018 Haploinsufficiency of the Mouse Atp6v1b1 Gene Leads to a Mild Acid-Base Disturbance with Implications for Kidney Stone Disease. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 12 29843146
2016 Clinical and molecular findings in three Moroccan families with distal renal tubular acidosis and deafness: Report of a novel mutation of ATP6V1B1 gene. Current research in translational medicine 12 27140593
2015 Mutations in exons 3 and 7 resulting in truncated expression of human ATP6V1B1 gene showing structural variations contributing to poor substrate binding-causative reason for distal renal tubular acidosis with sensorineural deafness. Journal of biomolecular structure & dynamics 8 25517796
2022 Genetic heterogeneity in GJB2, COL4A3, ATP6V1B1 and EDNRB variants detected among hearing impaired families in Morocco. Molecular biology reports 6 35301649
2011 Why is hypercalciuria absent at diagnosis in some children with ATP6V1B1 mutation? Pediatric nephrology (Berlin, Germany) 6 21614596
2010 Founder mutations in the ATP6V1B1 gene explain most Cypriot cases of distal renal tubular acidosis: first prenatal diagnosis. Nephron. Clinical practice 6 20805693
2006 ZMVHA-B1, the gene for subunit B of vacuolar H+-ATPase from the eelgrass Zostera marina L. Is able to replace vma2 in a yeast null mutant. Journal of bioscience and bioengineering 6 17189165
2023 The B1 H + -ATPase ( Atp6v1b1 ) Subunit in Non-Type A Intercalated Cells is Required for Driving Pendrin Activity and the Renal Defense Against Alkalosis. Journal of the American Society of Nephrology : JASN 5 37990364
2024 ATP6V1B1 regulates ovarian cancer progression and cisplatin sensitivity through the mTOR/autophagy pathway. Molecular and cellular biochemistry 4 38735913
2019 ATP6V1B1 recurrent mutations in Algerian deaf patients associated with renal tubular acidosis. International journal of pediatric otorhinolaryngology 4 31733597
2014 Investigation of ATP6V1B1 and ATP6V0A4 genes causing hereditary hearing loss associated with distal renal tubular acidosis in Iranian families. The Journal of laryngology and otology 4 25498251
2018 Novel compound heterozygous ATP6V1B1 mutations in a Chinese child patient with primary distal renal tubular acidosis: a case report. BMC nephrology 3 30558562
2015 Distal renal tubular acidosis with nerve deafness secondary to ATP6B1 gene mutation. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 3 25579729
2026 ATP6V1B1-Associated Inherited Distal Renal Tubular Acidosis in Children: Insights from a Literature Review. Children (Basel, Switzerland) 0 41897147
2025 Impairment of endocytosis-related factors FNBP1L, ARHGAP24, and ATP6V1B1 increases HIV-1 entry into dendritic cells. Journal of virology 0 40029073
2025 Distal Renal Tubular Acidosis With Sensorineural Deafness in a Saudi Female: A Case Report of an ATP6V1B1 Mutation in a Consanguineous Family. Cureus 0 41503293